Pre-earnings options volume in Heron Therapeutics is normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 11.6%, or 28c, after results are released. Median move over the past eight quarters is 9.3%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HRTX:
- Options Volatility and Implied Earnings Moves Today, March 12, 2024
- Heron Therapeutics Inc (HRTX) Q4 Earnings Cheat Sheet
- Biotech Alert: Searches spiking for these stocks today
- Heron Therapeutics Gains FDA Nod for ZYNRELEF® Expansion
- Heron Therapeutics announces FDA approval of ZYNRELEF indication expansion
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue